Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drainage Removal After Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy With Direct-to-Implant Prepectoral Breast Reconstruction on Postoperative Safety and Patient Satisfaction : A National Multicenter, Open, Randomized Controlled Study

NCT07237828 is registered in ClinicalTrials.gov with Du Zhenggui as lead sponsor.

NCT NCT07237828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drainage Removal After Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy With Direct-to-Implant Prepectoral Breast Reconstruction on Postoperative Safety and Patient Satisfaction : A National Multicenter, Open, Randomized Controlled Study
Lead sponsor
Du Zhenggui
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
June 30, 2032
Enrollment
379 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer